Чазова» (НМИЦ кардиологии) Министерства здравоохранения Российской Федерации) is one of the leading and oldest specialized medical institutions in Russia, whose activities are aimed at diagnosing, treating and preventing cardiovascular diseases.

At that time, the institute carried out extensive research on the possibilities of diagnosing and treating secondary forms of arterial hypertension.

An experimental laboratory for cardiac electrophysiology was also founded, where two antiarrhythmic drugs, ethmozine and ethacizine, were created.

Yuri Belenkov, an employee of the institute, becomes a pioneer in the development and implementation of this diagnostic method into wide practice.

[2] On June 5 of the same year, in the Department of Emergency Cardiology of the VKSC, for the first time in the world, a patient with myocardial infarction underwent thrombolysis using intracoronary administration of fibrinolysin at a dose 10 times lower than with intravenous administration, which led to the creation of a new method of treatment - thrombolytic therapy.

Legoshin and others) on this complex of buildings was awarded the USSR State Prize in Literature, Art and Architecture in 1990.